SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-183770
Filing Date
2021-06-07
Accepted
2021-06-07 08:09:11
Documents
12
Period of Report
2021-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d160787d8k.htm   iXBRL 8-K 32466
  Complete submission text file 0001193125-21-183770.txt   156393

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mgta-20210601.xsd EX-101.SCH 3092
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20210601_lab.xml EX-101.LAB 18121
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20210601_pre.xml EX-101.PRE 11419
5 EXTRACTED XBRL INSTANCE DOCUMENT d160787d8k_htm.xml XML 3347
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 21998310
SIC: 2834 Pharmaceutical Preparations